Harvard Pilgrim Health Care Home
  Learn more.
  Sign up for HPHConnect.
Medical Management
For Your Patient
News Center
Network Matters
Newsletter Archives
Newsletter Registration
Office Support
Provider Manual
Medicare Advantage
Research & Teaching
Resources & Links
Print    Text Size

Network Matters
News and Information for the
Harvard Pilgrim Health Care Network

August 2013

Specialty Pharmacy Updates 

Harvard Pilgrim’s Specialty Pharmacy Program has added the following medications.

Name Indication Coverage Available From
Signifor (pasireotide) Signifor is a self-injectable medication used to treat adults with Cushing’s disease for whom pituitary surgery is not an option or has not been curative. Pharmacy Benefit Curascript Pharmacy
Synribo (omacetaxine mepesuccinate) Synribo is an injectable medication used to treat chronic myeloid leukemia (CML). Medical
Curascript Pharmacy
TOBI is inhaled tobramycin used to treat pseudomonas aeruginosa in the lungs of people with cystic fibrosis. The maker of this drug recently stopped distributing it through retail pharmacies. Pharmacy Benefit  Curascript Pharmacy
Ravicti (glycerol phenylbutyrate)  Ravicti is an oral medication used to treat high blood levels of ammonia in patients with urea cycle disorders. Pharmacy Benefit  Curascript Pharmacy
Pomalyst (pomalidomide)  Pomalyst is an oral medication that is used to treat refractory multiple myeloma. Pharmacy Benefit  Curascript Pharmacy
Gattex (teduglutide) Gattex is a self-injectable medication used to treat adults with short bowel syndrome who are dependent on parenteral support.  Pharmacy Benefit
(prior authorization required)
Curascript Pharmacy
Cystaran (cysteamine) Cystaran is an ophthalmic solution used to treat crystal accumulation in cystinosis patients.  Pharmacy Benefit
Curascript Pharmacy
Kalbitor (ecallantide) Kalibitor is an injectable medication used for the treatment of acute hereditary angioedema (HAE) attacks. Medical
Curascript Pharmacy

Email this article to a colleague   

Receive Network Matters by e-mail

Network Matters Archives

Download printer-friendly version


Cardiac Medication Adherence Report Now Available

Reminder: Maintain Up-To-Date Panel Status Information


Intralesional Injection Procedures: No Prior Authorization Required

Medical Criteria for Electric and Myoelectric Prosthetics

TMS Now Covered with Prior Authorization

Continuous Glucose Monitoring Systems

New Prior Authorization Requirement for Six Medications

Gastric Emptying Payment Policy Update

P&T Committee Updates

Specialty Pharmacy Updates

Recognizing Postpartum Depression in the Primary Care Setting


Changes to HPHConnect New User Accounts

Qualitative Drug Screen Testing


Eric H. Schultz,
President and Chief Executive Officer

Richard Weisblatt PhD,
Senior Vice President, Provider Network

Annmarie Dadoly,

Kristin Edmonston,
Production Coordinator